# RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms

> **NCT00927966** · PHASE1 · COMPLETED · sponsor: **Suzanne George, MD** · enrollment: 21 (actual)

## Conditions studied

- Sarcoma
- Solid Tumor

## Interventions

- **DRUG:** RAD001
- **DRUG:** CP-751,871

## Key facts

- **NCT ID:** NCT00927966
- **Lead sponsor:** Suzanne George, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2013-11-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00927966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00927966, "RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00927966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*